Literature DB >> 6018456

Erythropoiesis in patients with renal failure undergoing chronic dialysis.

J W Eschbach, D Funk, J Adamson, I Kuhn, B H Scribner, C A Finch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6018456     DOI： 10.1056/NEJM196703232761202

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  33 in total

1.  Modeling red blood cell survival data.

Authors:  Julia Korell; Frederiek E Vos; Carolyn V Coulter; John B Schollum; Robert J Walker; Stephen B Duffull
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-10-14       Impact factor: 2.745

2.  Treatment of the anaemia of chronic renal failure with recombinant human erythropoietin.

Authors:  C G Winearls
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

Review 3.  The use of erythropoietin in renal failure.

Authors:  I C Macdougall; R D Hutton; G A Coles; J D Williams
Journal:  Postgrad Med J       Date:  1991-01       Impact factor: 2.401

4.  Analysis of anesthetic-related morbidity in human recipients of renal homografts.

Authors:  J A Aldrete; W Daniel; J W O'Higgins; J Homatas; T E Starzl
Journal:  Anesth Analg       Date:  1971 May-Jun       Impact factor: 5.108

5.  [Aplastic anemia in renal insufficiency--an inhibitory effect of the uremic serum on the erythropoetin?].

Authors:  U Essers; H Brass; K Spicher
Journal:  Klin Wochenschr       Date:  1970-01-15

6.  [Enteral iron resorption in patients with chronic renal insufficiency on maintenance dialysis. Measurement by whole body counter].

Authors:  A Blumberg; C Chappuis
Journal:  Klin Wochenschr       Date:  1971-01

7.  Erythropoietin: the developing story.

Authors:  P M Cotes
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-19

Review 8.  Androgens and erythropoiesis: past and present.

Authors:  S Shahani; M Braga-Basaria; M Maggio; S Basaria
Journal:  J Endocrinol Invest       Date:  2009-04-07       Impact factor: 4.256

9.  Histidine for treatment of uraemic anaemia.

Authors:  C Giordano; N G De Santo; S Rinaldi; D Acone; R Esposito; B Gallo
Journal:  Br Med J       Date:  1973-12-22

10.  Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial).

Authors:  Katherine A Barraclough; Euan Noble; Diana Leary; Fiona Brown; Carmel M Hawley; Scott B Campbell; Nicole M Isbel; David W Mudge; Carolyn L van Eps; Joanna M Sturtevant; David W Johnson
Journal:  BMC Nephrol       Date:  2009-07-28       Impact factor: 2.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.